Not a Capacity Problem, a Utilisation Problem
When Hari Kiran Chereddi started HRV Pharma in 2016, he could have built a plant. He chose not to. On his visits to manufacturers he kept seeing world class, FDA certified facilities running well below what they could do.
The Thinking Behind HRV's Model
In this conversation on ET Now's South Central, he explains the thinking behind HRV's model. India, he says, doesn't have a capacity problem. It has a utilisation problem, and that can be fixed without laying a single new brick.
Quality Through Trust and Systems
He also takes on the obvious question. If someone else makes the API, how do you guarantee quality? His answer is that trust has to be a system. Partners go through strict qualification, followed by standardised audits and live tracking across all 53 sites.
Growth Without Owning Manufacturing
The interview covers growth of 60 to 65% a year, a business started with ₹1 lakh that is still debt free, and his view that owning zero manufacturing is a founding principle rather than a phase HRV will outgrow on the way to ₹1,000 crore.
Featured in ET Now
